March 31 (Reuters) - Statera Biopharma Inc STAB.O :
* STATERA BIOPHARMA - ON MAR 25, RECEIVED LETTER FROM AVENUE
REGARDING DEFAULT WITH RESPECT TO LOAN, SECURITY AGREEMENT,
DATED AS OF APRIL 26, 2021
* STATERA BIOPHARMA - IN LETTER, AVENUE ALLEGES THAT CERTAIN
EVENTS OF DEFAULT UNDER LOAN AGREEMENT HAVE OCCURRED AND
CONTINUE TO EXIST
* STATERA - AVENUE ALLEGES CO IS IN VIOLATION OF AGREEMENT
DUE TO
CO'S FAILURE TO TIMELY DELIVER MONTHLY FINANCIAL STATEMENTS FOR
CERTAIN PERIODS
* STATERA- AVENUE ALLEGES CO IS IN VIOLATION OF AGREEMENT
DUE TO
CO'S FAILURE OBTAIN AVENUE'S CONSENT TO REPURCHASE CERTAIN
SECURITIES FROM STOCKHOLDERS
* STATERA - AVENUE ALLEGES CO IS IN VIOLATION OF AGREEMENT
DUE TO
CO'S FAILURE TO PAY PRINCIPAL AND INTEREST WHEN DUE, INCLUDING
ON MARCH 1, 2022
Further company coverage: STAB.O
((Reuters.Briefs@thomsonreuters.com;))